denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: educational grants from Karyopharm Therapeutics Inc., Sanofi Genzyme, and Oncopeptides, Inc.
Program: Satellite Symposia
Hematology Disease Topics & Pathways:
Diseases, Therapies, Myeloid Malignancies
Hematology Disease Topics & Pathways:
Diseases, Therapies, Myeloid Malignancies
Friday, December 4, 2020: 7:00 PM-10:00 PM
Chair:
Maria-Victoria Mateos, MD, PhD, University Hospital of Salamanca
Disclosures:
Mateos: Sanofi: Honoraria, Membership on an entity's Board of Directors or advisory committees; Regeneron: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; PharmaMar-Zeltia: Consultancy; Janssen-Cilag: Consultancy, Honoraria; GlaxoSmithKline: Consultancy; Pfizer: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Adaptive Biotechnologies: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Abbvie/Genentech: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Takeda: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Amgen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Celgene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Seattle Genetics: Honoraria, Membership on an entity's Board of Directors or advisory committees; Oncopeptides: Honoraria, Membership on an entity's Board of Directors or advisory committees; Roche: Honoraria, Membership on an entity's Board of Directors or advisory committees.
Speakers:
Enrique M. Ocio, MD, PhD, Hospital Universitario De Salamanca
,
Irene M. Ghobrial, MD, Dana-Farber Cancer Institute
and
Ajai Chari, MD, Icahn School of Medicine at Mount Sinai
Disclosures:
Ocio: Oncopeptides: Consultancy; MDS: Honoraria; Sanofi: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Speakers Bureau; Celgene: Consultancy, Honoraria; Secura-Bio: Consultancy; Takeda: Honoraria; GSK: Consultancy; Asofarma: Honoraria. Ghobrial: Genentech: Consultancy; GlaxoSmithKline: Consultancy; Noxxon Pharma: Consultancy; Novartis: Consultancy; Sanofi: Consultancy, Honoraria; Adaptive Biotechnologies: Consultancy, Honoraria; Cellectar: Honoraria; Karyopharm Therapeutics: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; Bristol-Myers Squibb: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; GNS Healthcare: Consultancy; AbbVie: Consultancy. Chari: Janssen: Consultancy, Research Funding; Celgene: Consultancy, Research Funding; Amgen: Consultancy, Research Funding; Bristol Myers Squibb: Consultancy; Pharmacyclics: Research Funding; Karyopharm: Consultancy; Sanofi Genzyme: Consultancy; Seattle Genetics: Consultancy, Research Funding; Oncopeptides: Consultancy; Takeda: Consultancy, Research Funding; Antengene: Consultancy; Glaxo Smith Kline: Consultancy; Secura Bio: Consultancy; Novartis: Honoraria; Array BioPharma: Honoraria; The Binding Site: Honoraria; Adaptive Biotechnology: Honoraria.
This program is designed to update physicians on the latest advancements in the clinical management of relapsed/refractory multiple myeloma, including novel agents under investigation, recently approved agents, and new combination approaches to treat this disease. In addition, this program will use case studies to apply recent findings to real-world case scenarios and will allow participants to reflect on how they might handle each scenario. Case-studies and panel discussions will be used by the Chair to challenge faculty on their treatment decisions and to give the opportunity for the audience to reflect on best practices and their own clinical decisions for higher educational engagement.
See more of: Satellite Symposia